SWA
FLNA

Sutton Wealth Advisors’s Filana Therapeutics FLNA Stock Holding History

Sutton Wealth Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$549 Buy
+33
New +$654 ﹤0.01% 816

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Sutton Wealth Advisors's FLNA Position: Q3 2023 in Review

Sutton Wealth Advisors opened a new position in Filana Therapeutics (FLNA) in Q3 2023: 33 shares worth $549. The stake represents ﹤0.01% of the portfolio and ranks #816 among its holdings.

140 funds tracked by Wall St. Rank hold FLNA as of Q3 2023.

  • Sutton Wealth Advisors held 33 shares of Filana Therapeutics worth $549 as of Q3 2023.
  • Filana Therapeutics was a new Sutton Wealth Advisors position in Q3 2023.
  • Filana Therapeutics made up ﹤0.01% of Sutton Wealth Advisors's portfolio in Q3 2023, its #816 holding.
  • 140 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2023.

Based on Sutton Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.